Try our Advanced Search for more refined results
July 13, 2009
Track this case
Gregory M. Sleet
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.Additional or older documents may be available in Pacer.
Allergan Inc. suffered a blow on Saturday when a Delaware federal judge ruled three patents covering the drugmaker's overactive bladder drug Sanctura XR were invalid, finding prior art rendered the patents' claims obvious.
Already a subscriber? Click here to login